CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)

NANot yet recruitingINTERVENTIONAL
Enrollment

15,000

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

July 31, 2028

Conditions
Coronary Artery DiseaseAtherosclerosisCardiovascular Inflammation
Interventions
DEVICE

CaRi-Heart® Analysis

"CaRi-Heart® is an artificial-intelligence-based software device that analyzes coronary CT angiography (CCTA) images to quantify coronary inflammation and generate a CaRi-Heart Risk Score. The analysis provides color-coded visualization and quantitative metrics derived from perivascular fat tissue characteristics, enabling improved assessment of coronary artery disease risk.~In this study, CaRi-Heart® analysis is applied prospectively to CCTA images obtained as part of standard clinical care. The results are reviewed by the interpreting physician and recorded to determine whether the additional information affects diagnostic interpretation or management decisions. No additional imaging, radiation, or contrast exposure occurs."

Trial Locations (18)

17022

Corazon Imaging, Elizabethtown

17043

Corazon Imaging, Lemoyne

48044

Corazon Imaging, Macomb

48071

Corazon Imaging, Madison Heights

48072

Corazon Imaging, Berkley

48080

Corazon Imaging, Saint Clair Shores

48124

Corazon Imaging, Bay City

Corazon Imaging, Dearborn

48154

Corazon Imaging, Livonia

48183

Corazon Imaging, Trenton

48310

Corazon Imaging, Sterling Heights

48327

Corazon Imaging, Waterford

48377

Corazon Imaging, Novi

48532

Corazon Imaging, Flint

48603

Corazon Imaging, Saginaw

48723

Corazon Imaging, Caro

48858

Corazon Imaging, Mount Pleasant

49546

Corazon Imaging, Grand Rapids

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Corazon Medical PC

OTHER